Bridgeway Capital Management’s AtriCure ATRC Stock Holding History

Bridgeway Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,400	Closed	-$284K	–	1312
2019 Q3	$284K	Hold	11,400	–	–	﹤0.01%	1108
2019 Q2	$340K	Buy	+11,400	New	+$333K	﹤0.01%	1071
2015 Q1	–	Sell	-44,000	Closed	-$878K	–	1480
2014 Q4	$878K	Sell	44,000 -44,550	-50%	-$765K	0.02%	819
2014 Q3	$1.3M	Buy	88,550 +350	+0.4%	+$5.58K	0.03%	646
2014 Q2	$1.62M	Sell	88,200 -20,400	-19%	-$340K	0.04%	586
2014 Q1	$2.04M	Sell	108,600 -25,700	-19%	-$527K	0.06%	482
2013 Q4	$2.51M	Sell	134,300 -300	-0.2%	-$4.36K	0.08%	379
2013 Q3	$1.48M	Buy	134,600 +300	+0.2%	+$2.96K	0.05%	551
2013 Q2	$1.28M	Buy	+134,300	New	+$1.17M	0.05%	531

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Bridgeway Capital Management's ATRC Position: Q4 2019 in Review

Bridgeway Capital Management sold out of AtriCure (ATRC) in Q4 2019, closing a stake of 11,400 shares — an estimated $284K sold.

Bridgeway Capital Management first reported a position in ATRC in Q2 2013 and held it in 9 quarters. The position peaked at $2.51M in Q4 2013. 141 funds tracked by Wall St. Rank hold ATRC as of Q4 2019.

Bridgeway Capital Management reported no remaining AtriCure position as of Q4 2019 after selling out during the quarter.
Bridgeway Capital Management sold 11,400 AtriCure shares in Q4 2019, an estimated $284K.
Bridgeway Capital Management first reported a position in AtriCure in Q2 2013 and held it in 9 quarters.
Bridgeway Capital Management's AtriCure position peaked at $2.51M in Q4 2013.
141 funds tracked by Wall St. Rank held AtriCure as of Q4 2019.

Based on Bridgeway Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.